Kaempferol’s promise in fighting triple-negative breast cancer

FHS
July 24, 2024
10:23 pm

Review highlights kaempferol’s potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.

Global burden of heart failure: prevalence, incidence, and risk factors unveiled

Review provides a comprehensive overview of the global burden of heart failure, highlighting variations in prevalence, incidence, risk factors, and outcomes across different geographical regions

July 1, 2024

How do different organ microbiomes influence neuropsychiatric disorders?

Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.

October 19, 2023

Antibody engineering drives innovation in drug development

Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.